Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Sep-23 5:17 PM View:  | Versi Ebrahim CEO Director | Dmk Pharmaceuticals Corp (DMK) | 15-Sep-23 | Conversion | 729,200 | -- | -- | 392% 185.94K to 915.14K | |
| 30-May-23 6:16 PM View: | Versi Ebrahim CEO Director | Dmk Pharmaceuticals Corp (DMK) | 25-May-23 | Grant Duplicate | 177,194 | -- | -- | 2026% 8.74K to 185.94K | |
| 30-May-23 6:14 PM View: | Versi Jannine Director | Dmk Pharmaceuticals Corp (DMK) | 25-May-23 | Grant | 177,194 | -- | -- | 100% 0 to 177.19K | |
| 30-May-23 6:15 PM View: | Desai Meera J. Director | Dmk Pharmaceuticals Corp (DMK) | 25-May-23 | Grant | 3,138 | -- | -- | 100% 0 to 3.14K | |
| 30-May-23 6:16 PM View: | Versi Ebrahim CEO Director | Dmk Pharmaceuticals Corp (DMK) | 25-May-23 | Grant | 8,745 | -- | -- | 100% 0 to 8.74K | |
| 27-May-22 4:07 PM View: | Carlo Dennis J Phd | Dmk Pharmaceuticals Corp (DMK) | 25-May-22 | Option Exercise | 250,000 | -- | -- | 57% 442.46K to 692.46K | |
| 22-Mar-22 6:37 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-22 | Sale (Planned) | 10,490 | $0.60 | $6,286.66 | (2%) 452.95K to 442.46K | |
| 22-Mar-22 6:39 PM View: | Marguglio David J. SVP of Bus. Dev & CBO Director | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-22 | Sale (Planned) | 11,859 | $0.60 | $7,116.59 | (5%) 251.65K to 239.79K | |
| 22-Mar-22 6:39 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-22 | Sale (Planned) | 8,199 | $0.60 | $4,948.92 | (4%) 210.11K to 201.91K | |
| 22-Mar-22 6:35 PM View: | Benedicto David C. Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-22 | Sale (Planned) | 3,603 | $0.61 | $2,207.92 | (8%) 43.48K to 39.88K | |
| 14-Feb-22 10:00 PM View: | Marguglio David J. SVP of Bus. Dev & CBO Director | Dmk Pharmaceuticals Corp (DMK) | 09-Dec-21 | Gift | 13,000 | -- | -- | (5%) 264.65K to 251.65K | |
| 03-Dec-21 5:09 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 01-Dec-21 | Market Sale | 50,757 | $0.79 | $39,844.20 | (16%) 315.41K to 264.65K | (3%) |
| 03-Dec-21 5:10 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 01-Dec-21 | Market Sale | 35,553 | $0.79 | $27,909.10 | (14%) 245.66K to 210.11K | (3%) |
| 03-Dec-21 5:10 PM View: | Benedicto David C. Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 01-Dec-21 | Market Sale | 13,554 | $0.79 | $10,639.90 | (24%) 57.03K to 43.48K | (3%) |
| 03-Dec-21 5:08 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 01-Dec-21 | Market Sale | 47,870 | $0.79 | $37,578.00 | (10%) 500.82K to 452.95K | (3%) |
| 23-Feb-21 7:04 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 21-Feb-21 | Option Exercise | 22,258 | -- | -- | 8% 293.15K to 315.41K | |
| 23-Feb-21 7:07 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 21-Feb-21 | Option Exercise | 22,258 | -- | -- | 9% 254.81K to 277.07K | |
| 23-Feb-21 7:03 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 21-Feb-21 | Option Exercise | 13,911 | -- | -- | 6% 231.75K to 245.66K | |
| 23-Feb-21 7:01 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 21-Feb-21 | Option Exercise | 27,822 | -- | -- | 6% 473.0K to 500.82K | |
| 24-Nov-20 10:00 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 20-Nov-20 | Market Sale | 35,000 | $0.40 | $14,000.00 | (11%) 328.15K to 293.15K | (21%) |
| 24-Nov-20 4:26 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 20-Nov-20 | Market Sale | 35,000 | $0.41 | $14,182.00 | (12%) 289.81K to 254.81K | (19%) |
| 20-Nov-20 4:38 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Nov-20 | Market Sale (Planned) | 8,532 | $0.41 | $3,464.85 | (4%) 240.28K to 231.75K | (18%) |
| 20-Nov-20 4:33 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 18-Nov-20 | Market Sale (Planned) | 10,665 | $0.41 | $4,331.06 | (2%) 483.66K to 473.0K | (18%) |
| 20-Nov-20 4:32 PM View: | Daniels Karen K. VP of Operations | Dmk Pharmaceuticals Corp (DMK) | 18-Nov-20 | Market Sale (Planned) | 5,333 | $0.41 | $2,165.73 | (3%) 154.57K to 149.24K | (18%) |
| 20-Nov-20 4:31 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 18-Nov-20 | Market Sale (Planned) | 8,532 | $0.41 | $3,464.85 | (3%) 336.68K to 328.15K | (18%) |
| 20-Nov-20 4:34 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Nov-20 | Market Sale (Planned) | 7,229 | $0.41 | $2,935.70 | (2%) 297.04K to 289.81K | (18%) |
| 01-Oct-20 6:33 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 29-Sep-20 | Market Sale | 20,000 | $0.80 | $16,000.00 | (6%) 334.42K to 314.42K | 42% |
| 01-Oct-20 6:34 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 29-Sep-20 | Market Sale | 20,000 | $0.80 | $16,000.00 | (7%) 294.78K to 274.78K | 42% |
| 20-Aug-20 5:34 PM View: | Daniels Karen K. VP of Operations | Dmk Pharmaceuticals Corp (DMK) | 18-Aug-20 | Market Sale (Planned) | 5,480 | $0.87 | $4,790.07 | (4%) 146.14K to 140.66K | 47% |
| 20-Aug-20 5:41 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 18-Aug-20 | Market Sale (Planned) | 8,749 | $0.87 | $7,647.50 | (3%) 343.17K to 334.42K | 47% |
| 20-Aug-20 5:38 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Aug-20 | Market Sale (Planned) | 7,418 | $0.87 | $6,484.07 | (2%) 302.2K to 294.78K | 47% |
| 20-Aug-20 5:36 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Aug-20 | Market Sale (Planned) | 8,749 | $0.87 | $7,647.50 | (4%) 235.12K to 226.37K | 47% |
| 20-Aug-20 5:37 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 18-Aug-20 | Market Sale (Planned) | 10,929 | $0.87 | $9,553.04 | (2%) 466.77K to 455.84K | 47% |
| 20-May-20 4:07 PM View: | Daniels Karen K. VP of Operations | Dmk Pharmaceuticals Corp (DMK) | 19-May-20 | Private Sale (Planned) | 4,855 | $0.56 | $2,719.29 | (3%) 151.0K to 146.14K | |
| 20-May-20 4:09 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 18-May-20 | Market Sale (Planned) | 7,734 | $0.56 | $4,331.81 | (2%) 350.91K to 343.17K | 20% |
| 20-May-20 4:10 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 18-May-20 | Market Sale (Planned) | 6,532 | $0.56 | $3,658.57 | (2%) 308.73K to 302.2K | 20% |
| 20-May-20 4:08 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 18-May-20 | Market Sale (Planned) | 7,736 | $0.56 | $4,332.93 | (3%) 242.86K to 235.12K | 20% |
| 20-May-20 4:06 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 18-May-20 | Market Sale (Planned) | 9,913 | $0.56 | $5,552.27 | (2%) 476.68K to 466.77K | 20% |
| 19-Mar-20 6:40 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-20 | Market Sale (Planned) | 10,337 | $0.34 | $3,479.43 | (3%) 341.24K to 330.91K | (42%) |
| 19-Mar-20 6:39 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-20 | Market Sale (Planned) | 8,749 | $0.34 | $2,944.91 | (3%) 317.48K to 308.73K | (42%) |
| 19-Mar-20 6:41 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-20 | Market Sale (Planned) | 10,337 | $0.34 | $3,479.43 | (4%) 253.19K to 242.86K | (42%) |
| 19-Mar-20 6:35 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-20 | Market Sale (Planned) | 10,645 | $0.34 | $3,583.11 | (2%) 487.33K to 476.68K | (42%) |
| 19-Mar-20 6:36 PM View: | Daniels Karen K. VP of Operations | Dmk Pharmaceuticals Corp (DMK) | 18-Mar-20 | Market Sale (Planned) | 6,461 | $0.34 | $2,174.77 | (4%) 157.46K to 151.0K | (42%) |
| 26-Feb-20 5:59 PM View: | Daniels Karen K. VP of Operations | Dmk Pharmaceuticals Corp (DMK) | 24-Feb-20 | Market Sale (Planned) | 6,229 | $0.60 | $3,759.20 | (4%) 163.69K to 157.46K | 22% |
| 26-Feb-20 6:34 PM View: | Carlo Dennis J Phd President & CEO Director | Dmk Pharmaceuticals Corp (DMK) | 24-Feb-20 | Market Sale (Planned) | 12,436 | $0.60 | $7,505.13 | (2%) 499.76K to 487.33K | 22% |
| 26-Feb-20 6:01 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 24-Feb-20 | Market Sale (Planned) | 9,948 | $0.60 | $6,003.62 | (3%) 351.19K to 341.24K | 22% |
| 26-Feb-20 6:00 PM View: | Hopkins Robert O Chief Financial Officer | Dmk Pharmaceuticals Corp (DMK) | 24-Feb-20 | Market Sale (Planned) | 8,420 | $0.60 | $5,081.47 | (3%) 325.9K to 317.48K | 22% |
| 26-Feb-20 5:58 PM View: | Moss Ronald B. Chief Medical Officer | Dmk Pharmaceuticals Corp (DMK) | 24-Feb-20 | Sale (Planned) | 6,229 | $0.06 | $395.54 | (2%) 259.42K to 253.19K | |
| 16-Feb-21 10:00 PM View: | Daniels Karen K. VP of Operations | Dmk Pharmaceuticals Corp (DMK) | 21-Feb-20 | Option Exercise | 13,911 | -- | -- | 10% 135.33K to 149.24K | |
| 16-Feb-21 10:00 PM View: | Marguglio David J. SVP and Chief Business Officer Director | Dmk Pharmaceuticals Corp (DMK) | 21-Feb-20 | Option Exercise | 22,257 | -- | -- | 8% 270.89K to 293.15K |
